Advances in Eicosanoid Research

Nonfiction, Science & Nature, Science, Biological Sciences, Biochemistry, Biotechnology
Cover of the book Advances in Eicosanoid Research by , Springer Berlin Heidelberg
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart
Author: ISBN: 9783662040478
Publisher: Springer Berlin Heidelberg Publication: March 14, 2013
Imprint: Springer Language: English
Author:
ISBN: 9783662040478
Publisher: Springer Berlin Heidelberg
Publication: March 14, 2013
Imprint: Springer
Language: English

Over the last few years, we have witnessed tremendous progress in the field of eicosanoids and their therapeutic applications. Receptor an­ tagonists for leukotrienes have been tested as anti-inflammatories and are on the market as a treatment for asthma. Receptor agonists for pro­ stacyclin are being tested for the treatment of peripheral vascular dis­ ease, and selective inhibitors of cyclooxygenase type II were just ap­ proved for the treatment of rheumatoid arthritis. All these developments are the culmination of many years and man-hours of careful research. The field has now entered an upswing that will result in novel thera­ peutic applications within the next 10 years. New molecules and me­ diators have been identified, new enzymes and pathways elucidated and new therapeutic approaches have emerged. The concept of ei­ cosanoids as "pro-inflammatory" molecules is being challenged, and their role as regulators is increasingly recognized. In fact, some of these molecules may be important endogenous anti-inflammatory agents.

View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

Over the last few years, we have witnessed tremendous progress in the field of eicosanoids and their therapeutic applications. Receptor an­ tagonists for leukotrienes have been tested as anti-inflammatories and are on the market as a treatment for asthma. Receptor agonists for pro­ stacyclin are being tested for the treatment of peripheral vascular dis­ ease, and selective inhibitors of cyclooxygenase type II were just ap­ proved for the treatment of rheumatoid arthritis. All these developments are the culmination of many years and man-hours of careful research. The field has now entered an upswing that will result in novel thera­ peutic applications within the next 10 years. New molecules and me­ diators have been identified, new enzymes and pathways elucidated and new therapeutic approaches have emerged. The concept of ei­ cosanoids as "pro-inflammatory" molecules is being challenged, and their role as regulators is increasingly recognized. In fact, some of these molecules may be important endogenous anti-inflammatory agents.

More books from Springer Berlin Heidelberg

Cover of the book Yellow Biotechnology I by
Cover of the book Cybercrimes: A Multidisciplinary Analysis by
Cover of the book Contemporary Logistics in China by
Cover of the book Standards in der Medienproduktion by
Cover of the book Femtosekundenlaser by
Cover of the book Radiology Education by
Cover of the book Hearing — the Brain and Auditory Communication in Marsupials by
Cover of the book JIMD Reports, Volume 18 by
Cover of the book Global Constitutionalism by
Cover of the book Geological Well Logs by
Cover of the book Management kreativitätsintensiver Prozesse by
Cover of the book Total Hip Arthroplasty by
Cover of the book Gravity, Geoid and Marine Geodesy by
Cover of the book Philosophy in Science by
Cover of the book Fine Structure of Solar Radio Bursts by
We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy